Renaissance Global Science & Tech Cl O (USD) (ATL6737)
171.92
-5.62 (-3.17%)
USD |
May 18 2022
Returns Chart
Key Stats
Customize
| Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
|---|---|---|---|
| -- | 143.89M | 0.00% | -- |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
| 28.15M | -16.89% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| To obtain long-term capital appreciation by investing in a diversified portfolio of global companies involved mainly in telecommunications, biotechnology, computer hardware and software, and medical services and other scientific and technology based companies. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | ATL1027 |
| Equity Style | Large Cap/Growth |
| Fixed Income Style | -- |
| Broad Asset Class | -- |
| Broad Category | Equity |
| Category Name | Global Equity |
| Category Index | -- |
| Prospectus Objective | -- |
| Fund Owner Firm Name | CIBC Asset Management Inc |
| Broad Asset Class Benchmark Index | |
| ^SPTSX60TR | 100.0% |
| Manager Tenure | |
| Jonathan Mzengeza | 3.17 yrs |
| Michal Marszal | 2.89 yrs |
| Craig Jerusalim | 1.09 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
34
28.15M
-534.39M
Category Low
4.218B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of May 31, 2020
Performance Versus Category
As of May 18, 2022. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of May 18, 2022.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Microsoft Corp | 9.22% | 253.14 | -0.37% |
| Apple Inc | 6.27% | 137.35 | -2.46% |
| Alphabet Inc A | 5.46% | 2207.68 | -1.35% |
| Mastercard Inc A | 4.97% | 332.22 | -1.10% |
|
Takeda Pharmaceutical Co Ltd
|
4.53% | -- | -- |
| Tencent Holdings Ltd ADR | 4.52% | 44.87 | 3.13% |
| Fiserv Inc | 4.02% | 94.39 | 0.23% |
| Gilead Sciences Inc | 3.93% | 63.27 | 0.08% |
| Activision Blizzard Inc | 3.79% | 77.74 | -0.23% |
| Global Payments Inc | 3.74% | 120.47 | 0.67% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | -- |
| Administration Fee | -- |
| Performance Fee | -- |
| Switching Fee | Upgrade |
| Transaction Fee | -- |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | -- |
Basic Info
| Investment Strategy | |
| To obtain long-term capital appreciation by investing in a diversified portfolio of global companies involved mainly in telecommunications, biotechnology, computer hardware and software, and medical services and other scientific and technology based companies. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | ATL1027 |
| Equity Style | Large Cap/Growth |
| Fixed Income Style | -- |
| Broad Asset Class | -- |
| Broad Category | Equity |
| Category Name | Global Equity |
| Category Index | -- |
| Prospectus Objective | -- |
| Fund Owner Firm Name | CIBC Asset Management Inc |
| Broad Asset Class Benchmark Index | |
| ^SPTSX60TR | 100.0% |
| Manager Tenure | |
| Jonathan Mzengeza | 3.17 yrs |
| Michal Marszal | 2.89 yrs |
| Craig Jerusalim | 1.09 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (5-18-22) | 0.00% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 26.27 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of February 29, 2020
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 6/25/2009 |
| Last Annual Report Date | 8/31/2019 |
| Last Prospectus Date | -- |
| Share Classes | |
| ATL1027 | Commission-based Advice |
| ATL1227 | -- |
| ATL1637 | -- |
| ATL1645 | Fee-based Advice |
| ATL1745 | Institutional |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |